{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:51:16Z","timestamp":1740153076812,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Growth failure and growth hormone deficiency (GHD) have been reported as one accessory feature of GLUT1 deficiency syndrome (GLUT1DS), considered so far as a long-term adverse effects of ketogenic diet which is used to treat this condition<jats:bold>.<\/jats:bold><\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report the case of a 10-year-old Caucasian boy referred for short stature (height\u00a0\u2212\u20092.56 SDS) and delayed growth (growth velocity\u2009\u2212\u20094.33 SDS) who was diagnosed with GHD and started treatment with recombinant human growth hormone (rhGH). Because of his history of seizures with infantile onset, deceleration of head growth with microcephaly, ataxia, and moderate intellectual disability, a lumbar puncture was performed, which revealed a low CSF glucose concentration with a very low CSF-to-blood glucose ratio (&lt;\u20090.4), and genetic tests detected a <jats:italic>SLC2A1<\/jats:italic> gene exon 1 deletion confirming a diagnosis of GLUT1DS. Ketogenic diet was started. After 5.5\u2009years of rhGH treatment his height was normalized (\u2212\u20091.15 SDS). No side effects were reported during treatment, particularly on glycemic metabolism.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This is the first case of GHD in a Caucasian boy with GLUT1DS diagnosed before starting ketogenic diet, with a good response to rhGH treatment and absence of side effects. We speculate that GHD may represent a poorly recognized clinical feature of GLUT1DS rather than a complication due to ketogenic diet. Under-diagnosis may derive from the fact that growth failure is usually ascribed to ketogenic diet and therefore not further investigated. Pediatric neurologists need to be alerted to the possible presence of GHD in patients with GLUT1DS with slow growth, while pediatric endocrinologist need to refer GHD patients with additional features (motor and cognitive developmental delay, seizures with infantile onset, deceleration of head growth with acquired microcephaly, movement disorder with ataxia, dystonia, and spasticity) that may suggest GLUT1DS.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13052-020-00888-3","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:12:03Z","timestamp":1598415123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case report of glucose transporter 1 deficiency syndrome with growth hormone deficiency diagnosed before starting ketogenic diet"],"prefix":"10.1186","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-3915","authenticated-orcid":false,"given":"Gianluca","family":"Tornese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppa","family":"Patti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Pellegrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Faletra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Faleschini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egidio","family":"Barbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"888_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1440-1754.2006.00852.x","volume":"42","author":"DJ Coman","year":"2006","unstructured":"Coman DJ, Sinclair KG, Burke CJ, Appleton DB, Pelekanos JT, O'Neil CM, et al. Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome. J Paediatr Child Health. 2006;42:263\u20137.","journal-title":"J Paediatr Child Health"},{"key":"888_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/1817-1745.131481","volume":"9","author":"A Posar","year":"2014","unstructured":"Posar A, Santucci M. Unusual phenotype of glucose transport protein type 1 deficiency syndrome: a case report and literature review. J Pediatr Neurosci. 2014;9:36\u20138.","journal-title":"J Pediatr Neurosci"},{"key":"888_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.yebeh.2014.08.015","volume":"39","author":"A Ramm-Pettersen","year":"2014","unstructured":"Ramm-Pettersen A, Stabell KE, Nakken KO, Selmer KK. Does ketogenic diet improve cognitive function in patients with GLUT1-DS? A 6- to 17-month follow-up study. Epilepsy Behav. 2014;39:111\u20135.","journal-title":"Epilepsy Behav"},{"key":"888_CR4","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1542\/peds.2007-2410","volume":"122","author":"EG Neal","year":"2008","unstructured":"Neal EG, Chaffe HM, Edwards N, Lawson MS, Schwartz RH, Cross JH. Growth of children on classical and medium-chain triglyceride ketogenic diets. Pediatrics. 2008;122:e334\u201340.","journal-title":"Pediatrics."},{"issue":"Suppl","key":"888_CR5","first-page":"12","volume":"14","author":"Y Etani","year":"2005","unstructured":"Etani Y, Miyoshi Y, Mushiaki S, Ozono K. Growth hormone deficiency in cases of glucose transporter protein type 1 (GLUT1) deficiency [abstract]. Clin Pediatr Endocrinol. 2005;14(Suppl):12.","journal-title":"Clin Pediatr Endocrinol"},{"key":"888_CR6","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1111\/j.1651-2227.2012.02606.x","volume":"101","author":"Y Nakagama","year":"2012","unstructured":"Nakagama Y, Isojima T, Mizuno Y, Takahashi N, Kitanaka S, Igarashi T. Growth hormone deficiency: a possible complication of glucose transporter 1 deficiency? Acta Paediatr. 2012;101:e259\u201362.","journal-title":"Acta Paediatr"},{"key":"888_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF03344156","volume":"29","author":"E Cacciari","year":"2006","unstructured":"Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian cross-sectional growth charts (2 to 20 yr). J Endocrinol Investig. 2006;29:581\u201393.","journal-title":"J Endocrinol Investig"},{"key":"888_CR8","first-page":"246","volume":"11","author":"RJ Kuczmarski","year":"2002","unstructured":"Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat. 2002;11:246.","journal-title":"Vital Health Stat"},{"key":"888_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/adc.41.220.613","volume":"41","author":"JM Tanner","year":"1966","unstructured":"Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, height velocity, and weight velocity: British children, 1965. II Arch Dis Child. 1966;41:613\u201335.","journal-title":"II Arch Dis Child"},{"key":"888_CR10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MPG.0b013e3181da213e","volume":"51","author":"E Bertino","year":"2010","unstructured":"Bertino E, Spada E, Occhi L, Coscia A, Giuliani F, Gagliardi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51:353\u201361.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"888_CR11","volume-title":"The Wechsler intelligence scale for children\u2014fourth edition","author":"D Wechsler","year":"2003","unstructured":"Wechsler D. The Wechsler intelligence scale for children\u2014fourth edition. London: Pearson; 2003."},{"key":"888_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","volume":"40","author":"N Bayley","year":"1952","unstructured":"Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40:423\u201341.","journal-title":"J Pediatr"},{"key":"888_CR13","unstructured":"Italia. Determinazione dell\u2019Agenzia Italiana del Farmaco 29 luglio 2010. Modifica alla Nota AIFA 39 cui alla determinazione del 26 novembre 2009. Gazzetta Ufficiale. Serie Generale n. 270 del 18-11-2010."},{"key":"888_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fnut.2019.00112","volume":"6","author":"M Marchi\u00f2","year":"2019","unstructured":"Marchi\u00f2 M, Roli L, Lucchi C, Costa AM, Borghi M, Iughetti L, et al. Ghrelin plasma levels after 1 year of Ketogenic diet in children with refractory epilepsy. Front Nutr. 2019;6:112.","journal-title":"Front Nutr"},{"key":"888_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5603\/EP.2014.0046","volume":"65","author":"J Smyczy\u0144ska","year":"2014","unstructured":"Smyczy\u0144ska J, Stawerska R, Lewi\u0144ski A, Hilczer M. Incidence and predictors of persistent growth hormone deficiency (GHD) in patients with isolated, childhood-onset GHD. Endokrynol Pol. 2014;65:334\u201341.","journal-title":"Endokrynol Pol"},{"key":"888_CR16","doi-asserted-by":"publisher","first-page":"e604","DOI":"10.1152\/ajpendo.00012.2006","volume":"91","author":"WE Sonntag","year":"2006","unstructured":"Sonntag WE, Bennett C, Ingram R, Donahue A, Ingraham J, Chen H, et al. Growth hormone and IGF-I modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency. Am J Physiol Endocrinol Metab. 2006;91:e604\u201310.","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-020-00888-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00888-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T23:26:53Z","timestamp":1629934013000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-020-00888-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1186\/s13052-020-00888-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"type":"electronic","value":"1824-7288"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"28 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient and his parents provided their consent to submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}